Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
А. S. Tsareva
Observed names:
A. A. Tsareva,
A. S. Tsareva
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0000-0002-0635-9343
Observed ORCID:
0000-0002-0635-9343
OpenAlex ID:
A5044992418
Impact of PARP inhibitor maintenance therapy after initial treatment on the efficacy of subsequent therapy in ovarian cancer: a propensity score matching analysis
2025
·
А. А. Rumyantsev
, Т. Е. Tihomirova
, et al.
·
Malignant tumours
·
1
PDF
Therapy of BRCA-associated metastatic breast cancer. Efficacy and safety of talazoparib in the real-world clinical practice
2022
·
E. V. Lubennikova
, A. L. Kornietskaya
, et al.
·
Meditsinskiy sovet = Medical Council
·
1
PDF
Platinum-containing regimens in first-line therapy for cervical cancer: efficacy and safety analysis using a pseudorandomization method
2026
·
Alina V. Trusova
, A. A. Rumyantsev
, et al.
·
Surgery and Oncology
Efficacy of pembrolizumab plus lenvatinib versus alternative drug regimens in patients with recurrent endometrial cancer after platinum based chemotherapy: a retrospective cohort study
2026
·
Angelina N. Letuchikh
, A. А. Rumyantsev
, et al.
·
Surgery and Oncology
Induction chemotherapy regimens in malignant trophoblastic tumors with high risk of resistance: retrospective study
2025
·
A. S. Tsareva
, А. А. Rumyantsev
, et al.
·
Surgery and Oncology
PDF
Aspects of hypogonadism in oncological patients receiving antitumor treatment. Literature review
2025
·
M. E. Abramov
, E. R. Israelyan
, et al.
·
Cancer Urology
PDF
TIP regimen (paclitaxel, ifosfamide, cisplatin) in nonseminomatous germ cell tumors with poor-prognosis and unfavorable decline of serum tumor markers: final results
2025
·
E. R. Israelyan
, A. A. Tryakin
, et al.
·
Malignant tumours
PDF
Treatment of a patient with disseminated testicular germ cell tumor associated with terminal chronic kidney disease requiring hemodialysis
2024
·
A. S. Ablyametova
, A. V. Zorinova
, et al.
·
Malignant tumours
PDF
Choriocarcinoma of the ovaries: the role of molecular-genetic testing in the differential diagnosis of gestational and non-gestational forms
2024
·
A. N. Letuchikh
, A. S. Ablyametova
, et al.
·
Malignant tumours
Experience of using talazoparib in the aggressive course of BRCA2-associated triple-negative breast cancer: a clinical observation
2023
·
A. S. Tsareva
, E. V. Lubennikova
, et al.
·
Meditsinskiy sovet = Medical Council
Liver metastasis in estrogen receptor-positive HER 2-negative breast cancer. Ribociclib as prognosis-changing therapy
2022
·
E. V. Lubennikova
, A. S. Tsareva
, et al.
·
Medical alphabet
PDF
Show more works
View as search
Works count:
11
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type